Stay updated with breaking news from Diagnostics india. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Infectious Disease Diagnostic Market: Projected to Reach $39,941.37 Million by 2030 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
World Ovarian Cancer Day 2024: Can urine test detect the disease early? financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Reliance-owned Strand Life Sciences develops prenatal genomic diagnostics portfolio financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Affordable, made-in-India cervical cancer tests to be available soon—Check details financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], April 10: Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases (CVD) such as heart failure (HF). This breakthrough innovation is designed to bring testing closer to clinics and revolutionise patient care. The claim extension of the NT-proBNP biomarker, available exclusively on the cobas® h 232 system, aims to provide faster, more efficient diagnosis and management of HF in patients with type 2 diabetes (T2D). Business News | Roche Diagnostics India's Heart Failure Test for Diabetics Now Available on Its Point-of-care Device. ....